Dowpharma contract manufacturing services, a business unit of The Dow Chemical Company, signed its fourth collaboration agreement in the first quarter of 2006 for its Pfenex Expression Technology. The company will work with Insmed Inc. to express two proprietary proteins that are administered as a single complex, known as IPLEX, using Pfenex, a Pseudomonas-based technology. Dowpharma contends that Pfenex Expression Technology accelerates speed to market for vaccines and biotherapeutics by imp...